BioElectron, formerly known as Edison Pharmaceuticals, specializes in understanding how biology controls metabolism and develops drugs that detect defects in mitochondrial proteins. Their redox drugs are designed to treat mitochondrial diseases and adult neurodegenerative diseases. The company uses technology to automate scientific processes, including data collection and analysis, and develops tools to enhance collaboration and visibility within the organization. BioElectron is based in Mountain View, California and was founded in 2005.